John J. Russell, MD
Associate Director of Family Medicine Residency
Abington Memorial Hospital
Clinical Associate Professor of Family and Community Medicine
Temple University School of Medicine
Serena Cardillo, MD
Assistant Professor of Medicine
Division of Endocrinology, Diabetes, & Metabolism
Hospital of the University of Pennsylvania
Estimated amount of time to complete: 30 minutes
Clinical Case Challenge (Online)
Type 2 diabetes (type 2 DM) has reached an epidemic level in the United States. An estimated 25.8 million people have diabetes, about 8.3% percent of the U.S. population. About 90%-95% of adults who have diabetes have type 2 DM. Uncontrolled type 2 DM doubles a person’s risk for death, and on average individuals with type 2 DM lose 10-15 years of life. Because a large proportion of their patients continue to struggle with achieving optimal glycemic control, the management of type 2 DM is a major clinical challenge for primary care clinicians.
These clinicians have the opportunity to improve outcomes in patients with type 2 DM by making a greater commitment to achieving treatment goals and motivating their patients to improve self management; by expanding their ability to tailor treatment approaches and minimize side effects of treatment; and by gaining knowledge and competency regarding optimal use of new and emerging type 2 DM therapies. The goal of this continuing medical education activity is to enhance the ability of primary care clinicians to help their patients achieve optimal glycemic control, ultimately improving outcomes for patients.
Primary care clinicians and other health care practitioners interested or involved in the care of patients with type 2 diabetes.
Upon completion of this educational activity, the participant should be able to:
Modify treatment for patients with type 2 diabetes with inadequate glycemic control.
Incorporate the appropriate use of DPP-4 inhibitors into type 2 diabetes treatment plans to improve glycemic control.
It is the policy of Temple University School of Medicine; The Albert J. Finestone, MD Office for Continuing Medical Education to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored or jointly sponsored educational programs. All faculty, program planning committee members, and Temple University School of Medicine Continuing Medical Education staff participating in programs sponsored or jointly sponsored by Temple University School of Medicine are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation(s).
PLANNING COMMITTEE DISCLOSURE STATEMENT
Planning committee members have no financial relationships to disclose.
FACULTY DISCLOSURE STATEMENT
The information presented in this CME program represents the views and opinions of the individual contributors, and does not constitute the opinion or endorsement of, or promotion by, Temple University School of Medicine, Temple University Health System or its affiliates. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program participant must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Dr. Russell discloses that he is on the speakers' bureau for sanofi-aventis (immunizations).
Dr. Cardillo discloses that she receives research support from Bristol-Myers Squibb and AstraZeneca.
Accreditation Statement: Temple University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor Continuing Medical Education for physicians.
Certification Statement: Temple University School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
There is no fee to participate and receive credit.
Credit Provider Contact Information
School of Medicine
The Albert J. Finestone, MD Office for CME
3500 North Broad Street Philadelphia, PA 19140
Commercial Support Statements
This activity is supported through an educational grant from
Boehringer Ingelheim Pharmaceuticals, Inc.
This activity is supported through an educational grant from Eli Lilly and Company.
Minimum System Requirements:
• Pentium III, 600 MHz or Equivalent Processor
• 512 MB of RAM
• Windows XP, Vista, or 7
• Mac OS X
• 800x600 Monitor Resolution
• 16-bit Color
• 16 bit Sound Card with Speakers
Please turn off all pop-up blockers to ensure access to the educational activity.
Click on the "Start program" icon at the bottom of this page. You may start as a GUEST, but to claim credit, you must be a member. If you are not already registered as a user of this website, visit the login/registration page where you will be able to register as a new CMEcorner.com member or check existing registration information.
The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. The activity will take approximately 30 minutes to complete.
After the program has finished, click on the "Post-test" button.
Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen. A credit statement/certificate will be awarded for a score of 80% or better and may be printed immediately after passing the post-test.
Copyright © 2012. Temple University School of Medicine. All rights reserved.
Presented by Temple University School of Medicine and Medical Communications Media, Inc.
The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Temple University School of Medicine, Boehringer Ingelheim Pharmaceuticals, Inc., or Eli Lilly and Company. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.
To view our privacy policies, please visit: http://www.cmecorner.com/privacy.asp